As a multi-receptor agonist, it targets the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors
The exact dosage and injection site will be determined based on your unique needs and the products guidelines
Unlike injectables, this process supports the body's natural hormone cycles rather than replacing them
and increased reticulocyte count - Severe neurological symptoms Its important to note that the severity of the symptoms above depends on the extent of your B12 deficiency
This is a trend weve been seeing and its been seen by other studies as well that theres a shortage of these medications because its a much broader indication now than just diabetics its patients who are obese and dont have diabetes can get these medications, he told us
Some report mild, transient nausea in the first 1 to 2 weeks that resolves spontaneously